Singapore, March 27 -- The Health Sciences Authority received information related to the study titled 'Evaluating the Clinical and Economic Outcomes of Adding Semaglutide to Standard of Care in Adult Patients with Poorly Controlled Type 2 Diabetes'. The following are the other relevant details related to the trial:
Therapeutic Area: Endocrinology & Metabolism
Trial Centre(s):
National University Hospital
Trial Status: NA
Principal Investigator(s):
Dr Khoo Chin Meng
Published by HT Digital Content Services with permission from Health Daily Digest....